Lab
The Corvallis Clinic PC
The Corvallis Clinic PC was paid $2.11M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 7.8% of everything it billed.
33Billing provider infoTHE CORVALLIS CLINIC PC
CORVALLIS, OR 97330
CORVALLIS, OR 97330
33aNPI1699921296assigned 08/14/2008
33bProvider typeClinical Medical Laboratory
28Total paid$2.11M
24GClaims139,780
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Oregon
Rank by total paid#14 of 46
Median peer was paid$50K
This provider vs. median42×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,289 | $250K | |
| 2019 | 25,001 | $332K | |
| 2020 | 18,838 | $285K | |
| 2021 | 22,163 | $368K | |
| 2022 | 26,486 | $385K | |
| 2023 | 18,457 | $298K | |
| 2024incomplete | 12,546 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 7.8% | 6,894 | 6,064 | $165K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.9% | 3,164 | 2,903 | $146K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.9% | 3,162 | 2,901 | $146K |
| 80053 | Comprehensive metabolic panel | 6.5% | 10,898 | 9,520 | $137K |
| 36415 | Collection of venous blood by venipuncture | 5.8% | 30,208 | 24,869 | $123K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.7% | 1,683 | 1,593 | $120K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 9,397 | 8,028 | $115K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.2% | 1,860 | 1,787 | $88K |
| 80061 | Lipid panel | 4.0% | 4,934 | 4,249 | $85K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.4% | 5,866 | 5,231 | $72K |
| 84439 | 2.7% | 3,174 | 2,859 | $56K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.5% | 430 | 417 | $54K |
70 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.5% | 4,251 | $53K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.5% | 1,963 | $52K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.4% | 465 | $50K |
| 87186 | 2.2% | 1,960 | $46K | |
| 82728 | 2.0% | 2,710 | $41K | |
| 85027 | 1.9% | 4,370 | $41K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 3,499 | $38K |
| 82607 | 1.8% | 1,678 | $37K | |
| 81000 | 1.4% | 5,748 | $30K | |
| 87480 | 1.3% | 1,092 | $28K | |
| 87660 | 1.3% | 1,090 | $28K | |
| 87510 | 1.3% | 1,090 | $28K | |
| 86803 | <1% | 1,042 | $20K | |
| 83550 | <1% | 1,455 | $20K | |
| 87077 | <1% | 2,126 | $19K | |
| 84481 | <1% | 726 | $19K | |
| 86140 | <1% | 2,177 | $19K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 856 | $16K |
| 83540 | <1% | 1,509 | $16K | |
| 81025 | <1% | 1,260 | $14K | |
| 86592 | <1% | 1,716 | $13K | |
| 81514 | <1% | 76 | $12K | |
| 80050 | General health panel | <1% | 186 | $12K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 490 | $11K |
| 82570 | <1% | 1,567 | $11K | |
| 80081 | <1% | 104 | $10K | |
| 87340 | <1% | 475 | $9K | |
| 84460 | <1% | 1,154 | $9K | |
| 82043 | <1% | 879 | $9K | |
| 84450 | <1% | 1,161 | $8K | |
| 84075 | <1% | 1,144 | $8K | |
| 80076 | <1% | 731 | $8K | |
| 87210 | <1% | 934 | $8K | |
| 84155 | <1% | 1,144 | $8K | |
| 82040 | <1% | 1,140 | $8K | |
| 85651 | <1% | 1,710 | $8K | |
| 87653 | <1% | 93 | $4K | |
| 86703 | <1% | 178 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 63 | $3K |
| 84146 | <1% | 75 | $2K | |
| 87070 | <1% | 240 | $2K | |
| 82950 | <1% | 189 | $2K | |
| 83001 | <1% | 58 | $2K | |
| 84702 | <1% | 68 | $2K | |
| 87641 | <1% | 50 | $2K | |
| 87640 | <1% | 50 | $2K | |
| 0240U | <1% | 20 | $1K | |
| 87081 | <1% | 111 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 68 | $1K |
| 87205 | <1% | 242 | $989.10 | |
| 82670 | <1% | 14 | $804.44 | |
| 84403 | <1% | 12 | $590.07 | |
| 85652 | <1% | 348 | $544.18 | |
| 83690 | <1% | 56 | $540.79 | |
| 85018 | <1% | 67 | $438.15 | |
| 82247 | <1% | 45 | $372.02 | |
| 82248 | <1% | 44 | $354.55 | |
| 84550 | <1% | 47 | $329.02 | |
| 84153 | <1% | 13 | $310.55 | |
| 86762 | <1% | 12 | $305.62 | |
| 82746 | <1% | 13 | $253.49 | |
| 85610 | <1% | 69 | $239.06 | |
| 87150 | <1% | 12 | $229.86 | |
| 85014 | <1% | 27 | $178.04 | |
| 84156 | <1% | 22 | $169.21 | |
| 86900 | <1% | 26 | $158.94 | |
| 86850 | <1% | 14 | $123.84 | |
| 86901 | <1% | 13 | $89.94 | |
| 82565 | <1% | 29 | $50.19 | |
| 99000 | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAECH, JAMES (CEO)
Parent organizationCORVALLIS CLINIC PC
| Provider | Location | Paid |
|---|---|---|
| The Corvallis Clinic P C | Corvallis, OR | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.